The release of 3H-1-methyl-4-phenylpyridinium from bovine adrenal chromaffin cells is modulated by somatostatin

Regulatory Peptides

Volumn 137, Issue 3, 2006, Pages 107-113

  Ribeiro, Laura ^a   Martel, Fátima ^a   Azevedo, Isabel ^a  

^a Institute of Pharmacology and Therapeutics   (Portugal)

Author keywords

Bovine adrenal chromaffin cells; MPP+ release; Octreotide; Somatostatin

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 1,1 DIMETHYL 4 PHENYLPIPERAZINIUM; ACETYLCHOLINE; HEXAMETHONIUM; NICOTINE; OCTREOTIDE; PILOCARPINE; POTASSIUM CHLORIDE; SOMATOSTATIN; CATECHOLAMINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; NICOTINIC RECEPTOR;

ANIMAL CELL; ARTICLE; CHROMAFFIN CELL; CONTROLLED STUDY; COW; DRUG EFFECT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; ANIMAL; CATTLE; CELL CULTURE; IN VITRO STUDY; METABOLISM; SECRETION;

BOS TAURUS;

1-METHYL-4-PHENYLPYRIDINIUM; ACETYLCHOLINE; ANIMALS; CATECHOLAMINES; CATTLE; CELLS, CULTURED; CHOLINERGIC AGONISTS; CHOLINERGIC ANTAGONISTS; CHROMAFFIN CELLS; OCTREOTIDE; POTASSIUM CHLORIDE; RECEPTORS, NICOTINIC; SOMATOSTATIN;

EID: 33751537616     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2006.06.002     Document Type: Article

References (53)

1. Livett B.G. Adrenal medullary chromaffin cells in vitro. Physiol Rev 64 (1984) 1103-1161
2. Russ H., Gliese M., Sonna J., and Schömig E. The extraneuronal transport mechanism for noradrenaline (uptake2) avidly transports 1-methyl-4-phenylpyridinium (MPP+). Naunyn-Schmiedeberg's Arch Pharmacol 346 (1992) 158-165
3. Wall S.C., Gu H., and Rudnick G. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux. Mol Pharmacol 47 (1995) 544-550
4. Gründemann D., Schechinger B., Rappold G.A., and Schömig E. Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter. Nat Neurosci 1 (1998) 349-351
5. Martel F., Ribeiro L., Calhau C., and Azevedo I. Comparison between uptake2 and rOCT1: effects of catecholamines, metanephrines and corticosterone. Naunyn-Schmiedeberg's Arch Pharmacol 359 (1999) 303-309
6. Smith N.C., and Levi R. LLC-PK(1) cells stably expressing the human norepinephrine transporter: a functional model of carrier-mediated norepinephrine release in protracted myocardial ischemia. J Pharmacol Exp Ther 291 (1999) 456-463
7. Martel F., Keating E., Calhau C., Grundemann D., Schomig E., and Azevedo I. Regulation of human extraneuronal monoamine transporter (hEMT) expressed in HEK293 cells by intracellular second messenger systems. Naunyn-Schmiedeberg's Arch Pharmacol 364 (2001) 487-495
8. Martel F., Keating E., and Azevedo I. Effect of P-glycoprotein modulators on the human extraneuronal monoamine transporter. Eur J Pharmacol 422 (2001) 31-37
9. +) in PC12 cells. Auton Autacoid Pharmacol 22 (2002) 277-289
10. Ribeiro L., Azevedo I., and Martel F. Effect of cyclic AMP on PC12 cellular content and release of dopamine and 1-methyl-4-phenylpyridinium. Ann NY Acad Sci 971 (2002) 539-541
11. Javitch J.A., D'Amato R.J., Strittmatter S.M., and Snyder S.H. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc Natl Acad Sci U S A 82 (1985) 2173-2177
12. Pileblad E., and Carlsson A. Catecholamine-uptake inhibitors prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse brain. Neuropharmacology 24 (1985) 689-692
13. Dunigan C.D., and Shamoo A.E. Identification of the major transport pathway for the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium. Neuroscience 75 (1996) 37-41
14. Gründemann D., Liebich G., Kiefer N., Koster S., and Schömig E. Selective substrates for non-neuronal monoamine transporters. Mol Pharmacol 56 (1999) 1-10
15. Daniels A.J., and Reinhard Jr. J.F. Energy-driven uptake of the neurotoxin 1-methyl-4-phenylpyridinium into chromaffin granules via the catecholamine transporter. J Biol Chem 263 (1988) 5034-5036
16. + in mouse brain. Neurosci Lett 101 (1989) 83-88
17. Brazeau P., Vale W., Burgus R., Ling N., Butcher M., Rivier J., and Guillemin R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179 (1973) 77-79
18. Benali N., Ferjoux G., Puente E., Buscail L., and Susini C. Somatostatin receptors. Digestion 62 (2000) 27-32
19. Lundberg J.M., Hamberger B., Schultzberg M., Hokfelt T., Granberg P.O., Efendic S., Terenius L., Goldstein M., and Luft R. Enkephalin- and somatostatin-like immunoreactivities in human adrenal medulla and pheochromocytoma. Proc Natl Acad Sci U S A 76 (1979) 4079-4083
20. Epelbaum J., Bertherat J., Prevost G., Kordon C., Meyerhof W., Wulfsen I., Richter D., and Plouin P.F. Molecular and pharmacological characterization of somatostatin receptor subtypes in adrenal, extraadrenal, and malignant pheochromocytomas. J Clin Endocrinol Metab 80 (1995) 1837-1844
21. Bosch J., Lebrec D., and Jenkins S.A. Development of analogues: successes and failures. Scand J Gastroenterol Suppl 226 (1998) 3-13
22. Livett B.G., Boksa P., Dean D.M., Mizobe F., and Lindenbaum M.H. Use of isolated chromaffin cells to study basic release mechanisms. J Auton Nerv Syst 7 (1983) 59-86
23. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
24. Dar D.E., and Zinder O. Catecholamine secretion from bovine adrenal chromaffin cells induced by the dextrorotatory isomer of anatoxin-a. Gen Pharmacol 5 (1998) 737-740
25. Gerber S.H., Haunstetter A., Kruger C., Kaufmann A., Nobiling R., and Haass M. Role of [Na+]i and [Ca2+]i in nicotine-induced norepinephrine release from bovine adrenal chromaffin cells. Am J Physiol 269 (1995) C572-C581
26. Reinhard Jr. J.F., Diliberto Jr. E.J., Viveros O.H., and Daniels A.J. Subcellular compartmentalization of 1-methyl-4-phenylpyridinium with catecholamines in adrenal medullary chromaffin vesicles may explain the lack of toxicity to adrenal chromaffin cells. Proc Natl Acad Sci U S A 84 (1987) 8160-8164
27. Reinhard Jr. J.F., Diliberto Jr. E.J., and Daniels A.J. Characterization of cellular transport, subcellular distribution, and secretion of the neurotoxicant 1-methyl-4-phenylpyridinium in bovine adrenomedullary cell cultures. J Neurochem 52 (1989) 1253-1259
28. Corcoran J.J., Wilson S.P., and Kirshner N. Flux of catecholamines through chromaffin vesicles in cultured bovine adrenal medullary cells. J Biol Chem 259 (1984) 6208-6214
29. Livett B.G., and Marley P.D. Noncholinergic control of adrenal catecholamine secretion. J Anat 183 (1993) 277-289
30. Ochoa E.L., Chattopadhyay A., and McNamee M.G. Desensitization of the nicotinic acetylcholine receptor: molecular mechanisms and effect of modulators. Cell Mol Neurobiol 9 (1989) 141-178
31. Huganir R.L., Miles K., and Greengard P. Phosphorylation of the nicotinic acetylcholine receptor by an endogenous tyrosine-specific protein kinase. Proc Natl Acad Sci U S A 81 (1984) 6968-6972
32. Huganir R.L., Delcour A.H., Greengard P., and Hess G.P. Phosphorylation of the nicotinic acetylcholine receptor regulates its rate of desensitization. Nature 321 (1986) 774-776
33. Huganir R.L., and Miles K. Protein phosphorylation of nicotinic acetylcholine receptors. Crit Rev Biochem Mol Biol 24 (1989) 183-215
34. Paradiso K., and Brehm P. Long-term desensitization of nicotinic acetylcholine receptors is regulated via protein kinase A-mediated phosphorylation. J Neurosci 18 (1998) 9227-9237
35. Olias G., Viollet C., Kusserow H., Epelbaum J., and Meyerhof W. Regulation and function of somatostatin receptors. J Neurochem 89 (2004) 1057-1091
36. Boksa P., St-Pierre S., and Livett B.G. Characterization of substance P and somatostatin receptors on adrenal chromaffin cells using structural analogues. Brain Res 245 (1982) 275-283
37. Meyerhof W. The elucidation of somatostatin receptor functions: a current view. Rev Physiol Biochem Pharmacol 133 (1998) 55-108
38. Clapham D.E., and Neher E. Substance P reduces acetylcholine-induced currents in isolated bovine chromaffin cells. J Physiol (London) 347 (1984) 255-277
39. Livett B.G., and Zhou X.F. Substance P interactions with the nicotinic response. Ann NY Acad Sci 632 (1991) 249-262
40. Khalil Z., Marley P.D., and Livett B.G. Effect of substance P on nicotine-induced desensitization of cultured bovine adrenal chromaffin cells: possible receptor subtypes. Brain Res 459 (1988) 289-297
41. Livett B.G., and Boksa P. Receptors and receptor modulation in cultured chromaffin cells. Can J Physiol Pharmacol 62 (1984) 467-476
42. Inoue M., and Kuriyama H. Somatostatin inhibits the nicotinic receptor-activated inward current in guinea pig chromaffin cells. Biochem Biophys Res Commun 174 (1991) 750-757
43. Role L.W., Leeman S.E., and Perlman R.L. Somatostatin and substance P inhibit catecholamine secretion from isolated cells of guinea-pig adrenal medulla. Neuroscience 6 (1981) 1813-1821
44. Tsujimoto A., and Morita K. Facilitation of stimulation-evoked catecholamine release by somatostatin in dog perfused adrenal glands. Naunyn-Schmiedeberg's Arch Pharmacol 321 (1982) 52-55
45. Ribeiro L., Martel F., and Azevedo I. Effect of somatostatin on the release of adrenaline and noradrenaline from bovine adrenal chromaffin cells. In: Borges R., and Gandia L. (Eds). Cell Biology of the Chromaffin Cell (2004), Instituto Teófilo Hernando, Madrid 147-149
46. Mizobe F., Kozousek V., Dean D.M., and Livett B.G. Pharmacological characterization of adrenal paraneurons: substance P and somatostatin as inhibitory modulators of the nicotinic response. Brain Res 178 (1979) 555-566
47. Moeller I., Bunn S.J., and Marley P.D. Actions of somatostatin on perfused bovine adrenal glands and cultured bovine adrenal medullary cells. Brain Res 484 (1989) 192-202
48. Knight D.E., and Baker P.F. Calcium-dependence of catecholamine release from bovine adrenal medullary cells after exposure to intense electric fields. J Membr Biol 68 (1982) 107-140
49. Kent C., and Coupland R.E. On the uptake of exogenous catecholamines by adrenal chromaffin cells and nerve endings. Cell Tissue Res 221 (1981) 371-383
50. Kent C., and Coupland R.E. On the uptake and storage of 5-hydroxytryptamine, 5-hydroxytryptophan and catecholamines by adrenal chromaffin cells and nerve endings. Cell Tissue Res 236 (1984) 189-195
51. Kobayashi S., and Coupland R.E. Morphological aspects of chromaffin tissue: the differential fixation of adrenaline and noradrenaline. J Anat 183 (1993) 223-235
52. Krause W., Michael N., Lubke C., Livett B.G., and Oehme P. Substance P and epibatidine-evoked catecholamine release from fractionated chromaffin cells. Eur J Pharmacol 328 (1997) 249-254
53. Lhoste F. Physiological and pharmacologic studies of the adrenal medulla by the measurement of plasma catecholamine levels. J Pharmacol 16 (1985) 139-151